REverse transcriptase ACTivity (REACT) assay for point-of-care measurement of established and emerging antiretrovirals for HIV treatment and prevention.

Saved in:
Bibliographic Details
Title: REverse transcriptase ACTivity (REACT) assay for point-of-care measurement of established and emerging antiretrovirals for HIV treatment and prevention.
Authors: Brainerd C; Department of Bioengineering, University of Washington, Seattle, USA., Singh MA; Department of Bioengineering, University of Washington, Seattle, USA., Tatka J; Department of Mechanical Engineering, University of Washington, Seattle, USA., Craig C; Department of Mechanical Engineering, University of Washington, Seattle, USA., Gilligan-Steinberg S; Department of Bioengineering, University of Washington, Seattle, USA., Panpradist N; Department of Bioengineering, University of Washington, Seattle, USA., Chang MM; Department of Bioengineering, University of Washington, Seattle, USA., Lutz B; Department of Bioengineering, University of Washington, Seattle, USA., Olanrewaju AO; Department of Bioengineering, University of Washington, Seattle, USA. ayokunle@uw.edu.; Department of Mechanical Engineering, University of Washington, Seattle, USA. ayokunle@uw.edu.
Source: Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2024 Dec; Vol. 416 (29), pp. 6809-6818. Date of Electronic Publication: 2024 Oct 28.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134327 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-2650 (Electronic) Linking ISSN: 16182642 NLM ISO Abbreviation: Anal Bioanal Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1618-2650
DOI:10.1007/s00216-024-05602-4